Using CB Insights proprietary data signals, we identified promising startups across 12 categories aiming to expand lifespans, from human cryopreservation to cellular reprogramming.
Populations are rapidly aging in major economies across the world — for longevity companies, that’s a big opportunity.
Longevity is a rather nascent but growing area of research for the biopharma industry — especially as tech advances in areas like AI and omics make it easier than ever to identify ways to manipulate the aging process. Existing consumer applications primarily focus on individuals wanting to stay healthy for longer, but the tide is shifting to products and services that slow or even reverse aging.
The rise of longevity tech will not just affect healthcare. Humans living longer, healthier lives would upend all sorts of societal and economic assumptions — impacting everything from retirement planning to insurance premiums to the size of the workforce to housing availability to trends in consumer demand. Few industries would be able to ignore the disruption from a longevity boom.
Below, we identify 64 companies shaping the longevity tech landscape. We define longevity tech as technology that helps individuals live healthier for longer periods of time, including tools that help reverse aging and/or treat age-related diseases.
Want to see more research? Join a demo of the CB Insights platform. If you’re already a customer, log in here.